Precisio Biotix Therapeutics, Inc. Announces Dosing of a 1st Patient with ClyO (Staph Lysin) to Treat a Multi Drug-Resistant Prosthetic Joint Infection Read More » July 3, 2025
Orphalan Partners with MAP International and the Wilson Disease Association to Provide Life-Changing Medicine to Underserved Communities Read More » June 27, 2025
Initiation of Commercialization of ProNephro AKI (NGAL) for Diagnostic Use in the US Read More » June 27, 2025
ACIP Recommends Use of Merck’s ENFLONSIA for Prevention of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season Read More » June 26, 2025